Researchers at Wake Forest University School of Medicine conducted a Phase III randomized, placebo-controlled trial to test donepezil, a cognitive-enhancing medicine used in the treatment of Alzheimer’s disease. The research team found that donepezil did not improve memory or other cognitive functions in survivors with cancer-related cognitive impairment.
The RegenMed Development Organization (ReMDO) announced today a new initiative titled Regulatory NavigatOR: a groundbreaking space aimed at providing unparalleled regulatory and scientific counsel to product developers navigating the complexities of the regenerative medicine pipeline.
Atrium Health Wake Forest Baptist and Forsyth County EMS have launched a program, believed to be the first in North Carolina, designed to improve outcomes for patients suffering from cardiac arrest.
Researchers at Wake Forest University School of Medicine have been approved for a $1 million award by the Patient-Centered Outcomes Research Institute (PCORI) for a methodology study.
A new study from researchers at Wake Forest University School of Medicine shows that school entry requirements are linked to an increase in human papillomavirus (HPV) vaccinations.
Racial discrimination experienced during midlife is associated with Alzheimer’s disease pathology, according to a new study from researchers at Wake Forest University School of Medicine and the University of Georgia. The findings appear online today in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.
Wake Forest University School of Medicine, Advocate Health and Vysnova Partners have been awarded a $3.4 million, four-year contract to study HIV, Mpox and other sexually transmitted infections (STIs).
In a new study, published online today in Scientific Reports, researchers found differences in how people with ICD process the consequences of their actions compared to those without ICD, both on and off medication.
Wake Forest University School of Medicine, the academic core of Advocate Health, is expanding another research study to Advocate Christ Medical Center, in Oak Lawn, Illinois, just outside Chicago. The study, which is testing a novel rehabilitation program designed for older patients hospitalized with acute heart failure, is funded by a five-year, $30 million grant, awarded to Wake Forest University School of Medicine in 2022 by the National Institute on Aging, part of the National Institutes of Health.
Wake Forest University School of Medicine has launched a new Translational Eye and Vision Research Center, located inside Biotech Place, in Innovation Quarter in Winston-Salem, North Carolina. Leaders envision the center serving as a visionary hub that will redefine the landscape of eye and vision research.
A team of scientists from Wake Forest University School of Medicine and the University of Southern California (USC) have demonstrated the first successful use of a neural prosthetic device to recall specific memories.
The Wake Forest Institute for Regenerative Medicine (WFIRM) is the recipient of an inaugural U.S. National Science Foundation (NSF) Engines Program award. The NSF Engines: Piedmont Triad Regenerative Medicine Engine is a regional project that provides an innovation ecosystem to stimulate workforce development, job creation, and economic growth through the development of technologies that benefit the emerging industry.
Researchers at Wake Forest University School of Medicine and the First Faculty of Medicine of Charles University in Prague, Czech Republic, have discovered a new genetic cause of inherited kidney disease.
The Wake Forest Institute for Regenerative Medicine, part of Wake Forest University School of Medicine, has been selected to lead the Armed Forces Institute of Regenerative Medicine (AFIRM) Consortium.
Researchers at Atrium Health and Wake Forest University School of Medicine have been approved for a $9.9 million research funding award from the Patient-Centered Outcomes Research Institute (PCORI), for a five-year study called “Remote Hypertension Tracking Help and Management to Reduce Disparities in Black Patients (RHYTHM-B).”
The Wake Forest Institute for Regenerative Medicine (WFIRM) has received a $6 million grant from the National Institute for Diabetes, Digestive and Kidney Diseases, part of the National Institutes of Health.
A new study from researchers at Wake Forest University School of Medicine shows that dopamine release in the human brain plays a crucial role in encoding both reward and punishment prediction errors.
Researchers at the Wake Forest Institute for Regenerative Medicine (WFIRM) have recently published an article in Nature Communications that demonstrates the potential of bioengineered human placental cells as a cure for Hemophilia A.
In 2021, researchers at Wake Forest University School of Medicine, the academic core of Advocate Health, received a $29.9 million, six-and-a-half-year award from the Patient-Centered Outcomes Research Institute (PCORI) and launched a multi-center, patient-randomized control trial, which is now expanding its footprint with the addition of two Advocate Health sites.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right